BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 27
• 28
• 29
• 30
• 31

• Business

  Celgene 3rd Quarter Profit Jumps on Revlimid Sales

  October 23, 2008

   · 

  1 min read
• BioMidwest

  Capstone Therapeutics Receives NASDAQ Notice Temporarily Suspending Minimum Bid Price Rule

  October 23, 2008

   · 

  1 min read
• Drug Development

  Threshold Pharmaceuticals, Inc. Presents Encouraging Additional Preliminary Findings From a Phase 1 Clinical Trial of TH-302 for Solid Tumors

  October 23, 2008

   · 

  1 min read
• Drug Development

  Addrenex Pharmaceuticals Initiates Phase 2 Trial on Its Novel Hypertension Drug, ADX415

  October 23, 2008

   · 

  2 min read
• Drug Development

  Altus Pharmaceuticals Inc. Announces Presentation of Phase 3 Trizytek Efficacy Data at the North American Cystic Fibrosis Conference

  October 23, 2008

   · 

  1 min read
• Business

  Ariad Pharmaceuticals, Inc. to Webcast Conference Call on Third Quarter 2008 Financial Results

  October 23, 2008

   · 

  1 min read
• Business

  Bristol-Myers Squibb Canada Profit Triples on Sale of Device Unit

  October 23, 2008

   · 

  1 min read
• Business

  OXiGENE Names John A. Kollins as CEO

  October 23, 2008

   · 

  5 min read
• Business

  Given Imaging Ltd. to Host Third Quarter 2008 Financial Results Conference Calls

  October 23, 2008

   · 

  1 min read
• BioForest

  Perceptronix to Exhibit at Canadian Association of General Practitioners in Oncology

  October 23, 2008

   · 

  1 min read